Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

172.03
Delayed Data
As of Jul 29
 +0.75 / +0.44%
Today’s Change
130.09
Today|||52-Week Range
181.81
+5.98%
Year-to-Date
Top 7 Research Reports for July 29, 2016
Jul 29 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene
Jul 28 / Zacks.com - Paid Partner Content
Company News for July 29, 2016
Jul 29 / Zacks.com - Paid Partner Content
Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View
Jul 28 / Zacks.com - Paid Partner Content
UCB (UCBJF) Posts 1H16 Results, Reaffirms 2016 Guidance
Jul 29 / Zacks.com - Paid Partner Content
2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK
Jul 28 / Zacks.com - Paid Partner Content
Amgen (AMGN) Stock Higher After Q2 Results, Raised Forecast
Jul 28 / TheStreet.com - Paid Partner Content
Facebook (FB) Owns Q2 Earnings on Huge Beat, Plus GRPN, GPRO and More
Jul 27 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Facebook, Amgen, Whole Foods and Groupon
Jul 28 / Zacks.com - Paid Partner Content
Dr. Michael Burry of 'The Big Short' Portfolio Review Shows Several Large Gains
Jul 27 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close171.28
Today’s open171.57
Day’s range170.53 - 172.26
Volume3,121,594
Average volume (3 months)2,868,795
Market cap$128.2B
Dividend yield2.33%
Data as of 4:14pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+7.78%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+6.49%
P/E ratio18.2
Price/Sales5.83
Price/Book4.58

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-1.77-2.18%
BIIBBiogen+0.90+0.31%
BAXBaxter International...-0.20-0.41%
NBIXNeurocrine Bioscienc...+0.08+0.16%
Data as of 4:14pm ET, 07/29/2016

Financials

Last reporting dateJuly 27, 2016
EPS forecast (this quarter)$2.73
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers

Search for Jobs